EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Non-Invasive Brain Stimulation Side Effect Scale (NIBS-SES): development of a brief, multilingual questionnaire for monitoring adverse effects in transcranial magnetic, electrical and ultrasound stimulation

Benjamin Selaskowski, Celine Koelsch, Chris Baeken, Daniel M Blumberger, André R Brunoni, René Hurlemann, Garikoitz Lerma-Usabiaga, Yoshihiro Noda, Pedro M Paz-Alonso, Casto Rivadulla, Junfeng Sun, Ganesan Venkatasubramanian und 4 weitere

Brain Stimulation · 2026-11 · 19 (6) · 103252

DOI: 10.1016/j.brs.2026.103252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Stimulation, 2026-11. Verfasst von Benjamin Selaskowski und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Network Stimulation, Department of Stereotactic and Functional Neurosurgery, University Hospital Cologne, Cologne, Germany; Department …. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Monitoring of adverse effects in neuromodulation relies largely on non-standardized or time-consuming instruments, limiting comparison of tolerability within and across transcranial magnetic stimulation (TMS), transcranial electrical stimulation (tES), and transcranial ultrasound stimulation (tUS). We developed the Non-Invasive Brain Stimulation Side Effect Scale (NIBS-SES), a brief questionnaire for repeated assessment of adverse effects. METHODS: The NIBS-SES was designed iteratively, with an initial version evaluated in 44 patients receiving TMS for major depression to assess repeated-use feasibility and adverse-effect patterns. Items were expanded based on a literature review of adverse-effect prevalences across TMS, tES, and tUS (n = 6415 individuals) and refined by 12 NIBS experts. The final version was professionally translated into 15 languages (Arabic, Basque, Catalan, Dutch, French, Galician, German, Hindi, Italian, Japanese, Korean, Mandarin Chinese, Persian, Portuguese, Spanish). RESULTS: Patient-reported adverse effects across 851 sessions declined despite titration of stimulation intensity. Prior-session occurrence was the strongest predictor of current-session reports (β = 4.73, p < .001), detectable only through repeated session-level assessment. Adverse effects during and between sessions showed different patterns of persistence, supporting their separate assessment. The literature review revealed substantial overlap across neuromodulation modalities, supporting a unified instrument. CONCLUSIONS: Our findings support the feasibility of repeated session-level assessment with the initial version, from which the final NIBS-SES was derived. This multilingual, open-access instrument comprises 10 within-session and 9 between-session items developed for monitoring across TMS, tES, and tUS (for questionnaire and digital implementation files, see OSF: https://doi.org/10.17605/OSF.IO/XZ3NB). Validation across brain stimulation modalities, protocols, and clinical populations will require prospective multi-site data.

Schlagwörter

Stichwörter der Autor:innen

Adverse-effect assessmentFocused ultrasoundMonitoringRepeated administrationtACStDCS

Autor:innen und Institutionen

  • Institute for Network Stimulation, Department of Stereotactic and Functional Neurosurgery, University Hospital Cologne, Cologne, Germany; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germa…
  • Ghent Experimental Psychiatry (GHEP) Lab, Faculty of Medicine and Health Sciences, Department of Head and Skin, Ghent University, Ghent, Belgium; Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neu…
  • Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health and Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Division of Interventional Psychiatry, Department of Psychiatry and Peter O'Donnell Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA.
  • Department of Psychiatry, School of Medicine & Health Sciences, University of Oldenburg, Bad Zwischenahn, Germany.
  • BCBL. Basque Center on Cognition, Brain and Language, Donostia-San Sebastián, Gipuzkoa, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Bizkaia, Spain.

Zitieren

APA

Selaskowski, B., Koelsch, C., Baeken, C., Blumberger, D. M., Brunoni, A. R., Hurlemann, R., Lerma-Usabiaga, G., Noda, Y., Paz-Alonso, P. M., Rivadulla, C., Sun, J., Venkatasubramanian, G., Sack, A. T., Rossi, S., Valero-Cabré, A., & Kiebs, M. (2026). The Non-Invasive Brain Stimulation Side Effect Scale (NIBS-SES): development of a brief, multilingual questionnaire for monitoring adverse effects in transcranial magnetic, electrical and ultrasound stimulation. Brain Stimulation, 19(6), 103252. https://doi.org/10.1016/j.brs.2026.103252

Vancouver

Selaskowski B, Koelsch C, Baeken C, Blumberger DM, Brunoni AR, Hurlemann R, et al. The Non-Invasive Brain Stimulation Side Effect Scale (NIBS-SES): development of a brief, multilingual questionnaire for monitoring adverse effects in transcranial magnetic, electrical and ultrasound stimulation. Brain Stimulation. 2026;19(6):103252. doi:10.1016/j.brs.2026.103252

BibTeX
@article{Selaskowski2026,
  author = {Selaskowski, Benjamin and Koelsch, Celine and Baeken, Chris and Blumberger, Daniel M and Brunoni, André R and Hurlemann, René and Lerma-Usabiaga, Garikoitz and Noda, Yoshihiro and Paz-Alonso, Pedro M and Rivadulla, Casto and Sun, Junfeng and Venkatasubramanian, Ganesan and Sack, Alexander T and Rossi, Simone and Valero-Cabré, Antoni and Kiebs, Maximilian},
  title = {The Non-Invasive Brain Stimulation Side Effect Scale (NIBS-SES): development of a brief, multilingual questionnaire for monitoring adverse effects in transcranial magnetic, electrical and ultrasound stimulation},
  journal = {Brain Stimulation},
  year = {2026},
  volume = {19},
  number = {6},
  pages = {103252},
  doi = {10.1016/j.brs.2026.103252}
}
Kostenlos starten →